The All India Muslim Personal Law Board is facing the wrath of a Muslim women's group, which has vowed to stop the maulvis from demanding a rollback of compulsory registration of marriages. Ahead of its proposed general body meeting at Mumbai, where the apex Muslim law body is to formally make its demand to the Centre, Muslim women are preparing to fight "gender excesses" by maulvis.  The Bhartiya Muslim Mahila Andolan...

-The Economic Times   Shibu Joseph ( Why I am Quitting my Job, ET, March 29) suggests, tongue-in-cheek, that he should quit the drudgery of corporate life and, instead, enjoy the "freebies" given to the aam aadmi, like the right to work under the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA).  I am not going to write on behalf of the crores of people who work in this programme, because I am...

There is evidence to show that growth is slowly becoming inclusive. But for the quality of life to improve, incomes must be complemented by infrastructure. For close to at least five years now inclusive growth has had a central place in the official discourse on the economy. The UPA II has itself worn its self-proclaimed success in delivering an inclusive growth as a badge of its effectiveness, not to mention its...

-The Times of India   The RTE Act is an opportunity to break gender, caste, class and community barriers that threaten to damage the social fabric of our democracy and create fissures that could be ruinous to the country, writes Union HRD minister Kapil Sibal. The Supreme Court judgment upholding the constitutional validity of the Right of Children to Free and Compulsory Education (RTE) Act has once again focused public attention on education....

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...